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S U M M A R Y
Babesiosis is a zoonotic disease that may be asymptomatic or result in severe clinical conditions, with
severe hemolysis, hepatic, and renal failure, in humans. Clinical symptoms depend on the species and
immune status of the host. The disease is especially severe in those of advanced age, those with an
immune deﬁciency, and the splenectomized. A severe case of babesiosis that developed in a splenectomy
patient is presented here; the patient was admitted from a rural region with severe anemia and a
deterioration in her general condition, with an initial diagnosis of malaria. In such situations, an
exchange transfusion (ET), in addition to antimicrobial treatment, could be lifesaving.
 2015 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Babesiosis is a zoonotic disease that is caused by an
intraerythrocytic protozoan; it is frequently transmitted through
deer ticks (Ixodes scapularis).1–3 Although human babesiosis is
often transmitted through tick bites, it can also be transmitted
through transfusions or transplacentally or perinatally. Humans
are an accidental host in babesiosis.4,5 The main Babesia species
that produce the disease in humans are Babesia microti, Babesia
divergens, and Babesia bovis.1 In a study conducted in Turkey, the
IgG antibody seropositivity for B. microti with the indirect
ﬂuorescence antibody method was found to be 6.23% (17/273)
in people living in rural areas of Sinop.6 A severe clinical picture
including hemolysis, HIV-derived immunosuppression, renal–
hepatic failure, and hypotension can develop, particularly in
patients who have undergone a splenectomy.4,5,7–9 Clindamycin +
quinine or atovaquone + azithromycin are the preferred antimi-
crobial treatments.§ This case was presented at the Turkish EKMUD Congress in Antalya, Turkey,
2015, as a secondary presentation in the Turkish language.
* Corresponding author. Tel.: +90 506 2488521.
E-mail address: estanyel@yahoo.com.tr (E. Tanyel).
http://dx.doi.org/10.1016/j.ijid.2015.07.019
1201-9712/ 2015 Published by Elsevier Ltd on behalf of International Society for Infect
creativecommons.org/licenses/by-nc-nd/4.0/).A case of severe babesiosis that developed in a woman living in
the countryside is presented here. The patient had undergone a
splenectomy 15 years previously due to a ﬁrearm injury.
2. Case report
In August 2014, a 28-year-old housewife was admitted to
health center in Ordu province with complaints of malaise,
jaundice, and general impairment. She had severe anemia
(hemoglobin 5.5 g/dl), and so was referred to the hematology
department. A large number of signet ring forms were observed
within the erythrocytes in the peripheral smear. Consequently she
was hospitalized in the infectious diseases clinic with an initial
diagnosis of malaria.
The patient had a tendency to sleep, so her medical history was
obtained from her relatives. It was learned that she had been
experiencing her complaints for approximately 1 month and that
she was living in a rural area. She had not traveled to any other
cities or countries. Fifteen years earlier she had undergone a
splenectomy due to a ﬁrearm injury. Upon physical examination,
the patient’s body temperature was 37.8 8C, her blood pressure
was 110/70 mmHg, her respiratory rate was 24 breaths/min, her
pulse was 110 beats/min, her sclera and skin were icteric, and herious Diseases. This is an open access article under the CC BY-NC-ND license (http://
Figure 2. Giemsa stain of a thin blood smear after the exchange transfusion.
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cell count was 17.6  109/l (neutrophils 72%, lymphocytes 11%),
hemoglobin was 5.5 g/dl, hematocrit was 13.2%, platelet count was
114  109/l, aspartate aminotransferase (AST) was 469 U/l (normal
range 8–46 U/l), alanine aminotransferase (ALT) was 89 U/l
(normal range 0–35 U/l), total/direct bilirubin was 10.6/2.9 mg/
dl, lactate dehydrogenase (LDH) was 4053 U/l (normal range 0–
480 U/l), creatine phosphokinase (CPK) was 1576 U/l (normal
range 35–195 U/l), and creatinine was 2.5 mg/dl (normal range
0.4–1.4 mg/dl). Tests for hepatitis B surface antigen (HBsAg),
antibody to hepatitis C virus (anti-HCV), and antibody to HIV (anti-
HIV) were all negative, as was a Brucella tube agglutination test. In
the peripheral blood samples, a large number of ring-shaped
parasites (>50%) were observed within the erythrocytes on Giemsa
staining (Figure 1).
The patient was diagnosed with babesiosis according to the
history and the evaluation of the preparations. Treatment with
quinine (3  650 mg, orally) + clindamycin (4  600 mg, intrave-
nous) was initiated. Patient blood samples were sent to Cerrahpas¸ a
University and the causative agent was identiﬁed as Babesia
divergens by PCR.
DNA was extracted with a commercial nucleic acid isolation kit
(Roche, Germany), in accordance with the manufacturer’s protocol.
Babesia spp DNA was investigated by PCR. For PCR ampliﬁcation of
the 18s rRNA gene, the forward primer GACACAGGGAGGTAGT-
GACAAG and reverse primer CTAAGAATTTCACCTCTGACAGT were
used.10 The reaction mixture contained 25 ml of ready-to-use PCR
Master Kit (containing dNTPs, Taq DNA polymerase, and MgCl2;
Thermo, Finland), 1 ml of each primer (ﬁnal concentration
25 pMol), and 10 ml of template, in a ﬁnal volume of 50 ml. The
PCR ampliﬁcation was performed with the following program:
94 8C for 2 min, followed by 40 cycles of 94 8C for 45 s, 54 8C for 45 s
and 72 8C for 60 s. The PCR reaction was ended with a ﬁnal
extension at 72 8C for 10 min. The ampliﬁed PCR product was
controlled by electrophoresis on 1.5% agarose gel in 0.5 Tris–
borate–ethylenediaminetetraacetic acid (TBE) buffer, stained with
ethidium bromide, and visualized under UV light using a
transilluminator.
The positive PCR product was puriﬁed using the High Pure PCR
Puriﬁcation Kit (Roche, Germany) following the manufacturer’s
protocol, and then bidirectional DNA sequencing was performed
with BigDye 3.1 sequencing chemistry (Life Technologies, USA).
Chromatograms were edited and aligned with DNASTAR software.
Database searches and sequence comparisons were performed
with the BLAST tool provided by the National Centre for
Biotechnology (http://blast.ncbi.nlm.nih.gov/Blast.cgi). The DNAFigure 1. Giemsa stain of a thin blood smear showing ring forms of intraerythrocytic
trophozoites of Babesia divergens before the exchange transfusion.sequence showed 100% similarity to the Babesia divergens isolate
DP-1576b 18S ribosomal RNA gene, partial sequence (GenBank
accession number JX083979.1)
As the patient’s clinical condition was poor and she had severe
ﬁndings of babesiosis, she was referred to the hematology clinic
and an exchange transfusion (ET) was performed. The parasitemia
was initially >50%, and this decreased signiﬁcantly (<10%) with
erythrocyte ET (Figure 2). Within 48 h after the ET, the parasitemia
had decreased signiﬁcantly and it became undetectable on
peripheral blood smear. The quinine and clindamycin therapy
was completed at the end of 10 days and the patient was
discharged.
3. Discussion
Babesiosis, which is transmitted through tick bites and can
cause severe clinical conditions in immunocompromised patients,
is a disease that can be diagnosed with thin and/or thick smears.
The causative agent is observed as a round or oval shape within the
erythrocyte. Although the brown pigment deposits (hemozoin)
that are observed for the Plasmodium species are not observed in
babesiosis, its merozoites are tetrad in structure. Furthermore,
different from malaria, the presence of sudden excessive hemoly-
sis, due to asynchronous production and non-periodic symptoms,
is typical in babesiosis.1 When the data from Turkey were
investigated, it was found that although local cases of malaria
have decreased over the years, important malaria cases have been
observed.11–14 When signet ring forms are observed within
erythrocytes in peripheral smears in the presence of an epidemio-
logical history and periodic high fever, malaria could be considered
as the primary diagnosis.15,16
In the present case, malaria was assumed to be the initial
diagnosis, since the ring-shaped parasites were observed within
the erythrocytes in the ﬁrst evaluation, and the region around
Turkey is not endemic for human babesiosis. However, the absence
of an epidemiological history, the presence of a large number of
ring forms within a single erythrocyte, the extreme anemia,
previous splenectomy, and the absence of a periodic high fever
suggested babesiosis. Furthermore, the patient had no history of
known tick contact, she had not traveled to endemic regions, she
had no history of working in stock farming, and she had no recent
history of blood transfusions for the transmission of babesiosis.
In the literature, it is mentioned that B. divergens is frequently
isolated in human babesiosis cases reported in Europe and that it
E. Tanyel et al. / International Journal of Infectious Diseases 38 (2015) 83–85 85causes a severe disease in patients who have undergone a
splenectomy and are immunosuppressed.3–5,7,8 However, no case
report was found in a literature search using PubMed and Science
Citation Index.17–19 The present case is the ﬁrst case reported from
Turkey as an international report in which B. divergens was
detected in blood samples by PCR. Babesia ovis, Babesia bigemina,
and B. microti have been isolated in ticks from sheep and goats in
the Black Sea region of Turkey.20,21
All active babesiosis cases should be treated.5 A combination of
either atovaquone + azithromycin or quinine + clindamycin for 7–
10 days is the preferred treatment.4,5 It has been reported that a
more successful outcome could be obtained from clindamycin +
quinine therapy in >10% of the cases with organ failure or
parasitemia.9 In the current case, the combination quinine +
clindamycin was preferred in the ﬁrst instance, due to the presence
of high parasitemia and the deterioration in the patient’s general
condition.
An ET with erythrocytes or whole blood may be conducted in
cases of severe babesiosis (high parasitemia >10%, severe
hemolysis (hemoglobin <10 g/dl), splenectomy, coma, hypoten-
sion, congestive heart failure, pulmonary edema, and heart failure)
in addition to antimicrobial treatment.1,3,5,22 The aim of this
method is to exchange the erythrocytes containing parasites and
remove the toxic harmful metabolites.3,4,9 As the Babesia species
has no exoerythrocytic phase, the removal of erythrocytes with
parasites is curative.1,4,22 In a study including asplenic patients
under immunosuppressive therapy who had been diagnosed with
babesiosis, it was demonstrated that parasitemia decreased with
ET treatment with whole blood and/or erythrocytes; it was also
reported that ET together with medical therapy is lifesaving.22 In a
study investigating 34 cases diagnosed with babesiosis and their
complications, a signiﬁcant decrease in parasite load was reported
in seven cases with high parasitemia.23 In an asplenic female who
was diagnosed with babesiosis, it was reported that the
parasitemia rate of 13% decreased to 0.3% after ET.24 In the present
case, the parasitemia was initially >50%, and it decreased
signiﬁcantly with erythrocyte ET. The parasitemia decreased to
<10% after erythrocyte ET in the present case in which the patient
was in a poor general condition, had a tendency to sleep, and had
extreme anemia. Therefore, ET may have been lifesaving in the
present asplenic case.
In conclusion, babesiosis is a disease that can be diagnosed with
a detailed epidemiological history and an examination of thin and/
or thick smear preparations, which is a simple and rapid method.
Treatment should be initiated promptly, as the disease may
become progressively more severe in immunocompromised and
asplenic individuals. ET can be lifesaving in patients with extreme
cases of the disease and a high parasite load; therefore, it could be
performed in addition to medical therapy.Conﬂict of interest: The authors state that they have no conﬂict of
interest.
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